TY - JOUR AU - Li, Haojia AU - Whitney, Jon AU - Bera, Kaustav AU - Gilmore, Hannah AU - Thorat, Mangesh A. AU - Badve, Sunil AU - Madabhushi, Anant PY - 2019 DA - 2019/10/17 TI - Quantitative nuclear histomorphometric features are predictive of Oncotype DX risk categories in ductal carcinoma in situ: preliminary findings JO - Breast Cancer Research SP - 114 VL - 21 IS - 1 AB - Oncotype DX (ODx) is a 12-gene assay assessing the recurrence risk (high, intermediate, and low) of ductal carcinoma in situ (pre-invasive breast cancer), which guides clinicians regarding prescription of radiotherapy. However, ODx is expensive, time-consuming, and tissue-destructive. In addition, the actual prognostic meaning for the intermediate ODx risk category remains unclear. SN - 1465-542X UR - https://doi.org/10.1186/s13058-019-1200-6 DO - 10.1186/s13058-019-1200-6 ID - Li2019 ER -